NCT07378423Recruiting
Questionnaire on Congenital Cancer Signs Through Self-Assessment
Questionnaire on Congenital Cancer Signs Through Self-Assessment (QUOCCAS)
Source: ClinicalTrials.gov · Last updated 1 May 2026
Brief summary (registry, in English)
This clinical trial tests whether a patient- and caregiver-completed questionnaire (QUOCCAS) can accurately help identify children and adolescents with cancer who may have an underlying cancer predisposition syndrome (CPS). The study will also evaluate whether providing families with an educational brochure before their clinic visit improves their understanding of genetics and their satisfaction with care. The main questions it aims to answer are: * Does QUOCCAS identify children at risk for CPS as accurately as physician-based tools and compared to genetic testing? * Does the Pre-Visit Preparation (PVP) brochure improve caregiver knowledge about genetics? * Does the PVP brochure improve caregiver satisfaction with the care and information they receive? Participants will: * Complete the QUOCCAS questionnaire about family history, clinical features, and cancer signs * Provide a blood or saliva sample for genetic testing (whole-exome or whole-genome sequencing) * Randomly receive or not receive the educational Pre-Visit Preparation brochure before completing the questionnaire * Complete brief surveys on their knowledge and satisfaction
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 205 (estimated)
- First submitted
- 18 Nov 2025
- Start date
- 1 Apr 2026
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Diseases
- Childhood cancers
- NCT number
- NCT07378423
What you commit to
- Study type: Interventional
- Planned participants: 205
- From 1 Apr 2026 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Over 21 years of age
Who the study is looking for
- The investigators will include newly diagnosed patients who received a cancer diagnosis included in the International Classification of Childhood Cancer version 3 (ICCC3) criteria, treated at participating hospitals
Age in the registry: - to 21 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Inselspital, Universitäts Kinderklinik (University Children's Hospital) Bern Coordinator of this site? Confirm its status | Bern | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.